| 摘要 |
<p>The present invention relates to methods of increasing the efficacy of existing drugs, and more particularly relates to modifying known drugs by combining them with obligonucleotides to produce chimeric drug-oligonucleotide molecules having superior targeting,uptake and retention than the unmodified known drug.</p> |
